Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulax injection for trapezius hypertrophy
KCT0009443Phase 4Completed
- Sponsor
- Hugel
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in trapezius muscle hypertrophy, sponsored by Hugel. Started Sep 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
trapezius muscle hypertrophy
Beyond the preview
Go deeper on KCT0009443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009443.